Common use of Research Licence Clause in Contracts

Research Licence. Commencing on the Effective Date, and solely to the extent that it is agreed in any Collaboration Program or Research Pool Program that GSK should conduct work under the applicable Development Plan or Research Pool Program, Adaptimmune shall grant and hereby grants to GSK a non-exclusive licence in the Territory under the Adaptimmune Background and Adaptimmune’s interests in Collaboration Program IP, to ***Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission. the extent necessary for GSK’s performance of the Collaboration Program or Research Pool Program. The licence under this Section 5.4 shall expire on the earlier of (a) the date on which Adaptimmune rejects a Nomination Notice in accordance with Section 5.3.2; or (b) an exclusive licence being granted following exercise of the relevant Option, as applicable; or (c) expiration of the applicable Option Period without exercise of the Initial Program Option or Collaboration Program Option, as applicable; or (d) Completion of the Collaboration Program or Research Pool Program. The licence under this Section 5.4 shall be sub-licenseable to GSK’s Affiliates and subcontractors to the extent such Affiliates and subcontractors are performing any obligations under any Collaboration Program or the Research Pool Program.

Appears in 3 contracts

Samples: Collaboration and Licence Agreement (Adaptimmune Therapeutics PLC), Collaboration and Licence Agreement (Adaptimmune Therapeutics PLC), Collaboration and Licence Agreement (Adaptimmune LTD)

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.